285 related articles for article (PubMed ID: 16257420)
1. The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.
Chen X; McClatchy DB; Geller EB; Tallarida RJ; Adler MW
Life Sci; 2005 Dec; 78(4):329-33. PubMed ID: 16257420
[TBL] [Abstract][Full Text] [Related]
2. Interaction of cholecystokinin and somatostatin with a selective mu-opioid agonist and mu- and kappa-antagonists in thermoregulation.
Ghosh S; Geller EB; Adler MW
Brain Res; 1997 Jan; 745(1-2):152-7. PubMed ID: 9037404
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
Steinmiller CL; Young AM
Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.
Carr KD; Kutchukhidze N; Park TH
Brain Res; 1999 Mar; 822(1-2):34-42. PubMed ID: 10082881
[TBL] [Abstract][Full Text] [Related]
5. Effect of mu-, kappa-, and delta-selective opioid agonists on thermoregulation in the rat.
Handler CM; Geller EB; Adler MW
Pharmacol Biochem Behav; 1992 Dec; 43(4):1209-16. PubMed ID: 1361992
[TBL] [Abstract][Full Text] [Related]
6. Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappa receptor agonist-induced G-protein activation in the guinea pig caudate: further evidence of kappa receptor heterogeneity.
Heyliger SO; Jackson C; Rice KC; Rothman RB
Synapse; 1999 Dec; 34(4):256-65. PubMed ID: 10529720
[TBL] [Abstract][Full Text] [Related]
7. Mu and kappa opioid receptors of the periaqueductal gray stimulate and inhibit thermogenesis, respectively, during psychological stress in rats.
Cristina-Silva C; Martins V; Gargaglioni LH; Bícego KC
Pflugers Arch; 2017 Sep; 469(9):1151-1161. PubMed ID: 28374069
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception.
Campbell VC; Taylor RE; Tizabi Y
Alcohol Clin Exp Res; 2007 Aug; 31(8):1435-40. PubMed ID: 17550364
[TBL] [Abstract][Full Text] [Related]
9. The first suckling episode in the rat: the role of endogenous activity at mu and kappa opioid receptors.
Petrov ES; Varlinskaya EI; Smotherman WP
Dev Psychobiol; 2000 Nov; 37(3):129-43. PubMed ID: 11044861
[TBL] [Abstract][Full Text] [Related]
10. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
[TBL] [Abstract][Full Text] [Related]
11. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
12. The effect of selective opioid antagonists on butorphanol-induced feeding.
Levine AS; Grace M; Portoghese PS; Billington CJ
Brain Res; 1994 Feb; 637(1-2):242-8. PubMed ID: 8180802
[TBL] [Abstract][Full Text] [Related]
13. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
Lutfy K; Maidment NT
Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
Walker BM; Koob GF
Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
[TBL] [Abstract][Full Text] [Related]
15. Role of preoptic opioid receptors in the body temperature reduction during hypoxia.
Scarpellini Cda S; Gargaglioni LH; Branco LG; Bícego KC
Brain Res; 2009 Aug; 1286():66-74. PubMed ID: 19545549
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
Salmi P; Kela J; Arvidsson U; Wahlestedt C
Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
[TBL] [Abstract][Full Text] [Related]
17. [Effect of mu- and kappa-opioid receptor antagonists on aggressiveness of male mice with repeated experience of aggression].
Bondar' NP
Ross Fiziol Zh Im I M Sechenova; 2012 Jun; 98(6):681-92. PubMed ID: 23013006
[TBL] [Abstract][Full Text] [Related]
18. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
[TBL] [Abstract][Full Text] [Related]
19. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine.
Paronis CA; Waddell AB; Holtzman SG
Pharmacol Biochem Behav; 1993 Dec; 46(4):813-7. PubMed ID: 8309960
[TBL] [Abstract][Full Text] [Related]
20. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
